Effect of Perindopril on Cerebral Vasomotor Reactivity in Patients With Lacunar Infarction
- 1 August 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Stroke
- Vol. 35 (8) , 1899-1902
- https://doi.org/10.1161/01.str.0000131748.12553.ed
Abstract
Background and Purpose— There is growing evidence that pharmacologic interference with the renin-angiotensin system may reduce risk of stroke, although the mechanism is unclear. Impaired reactivity of cerebral vessels has recently been recognized as a risk factor for stroke. We examined the effect of the angiotensin-converting enzyme (ACE) inhibitor perindopril on cerebral vasomotor reactivity to acetazolamide in patients with lacunar cerebral infarction. Methods— We studied a cohort of male patients between 3 and 12 months after lacunar infarction confirmed on computed tomography. Each patient received perindopril 4 mg daily or matching placebo for 2 weeks in a randomized, double-blind, placebo-controlled crossover fashion. A 1-week washout period was observed between dosing periods. Cerebral vasomotor reactivity (increase in middle cerebral artery mean flow velocity in response to intravenous injection of 15 mg/kg acetazolamide) was measured before and after each dosing period using standard Doppler ultrasound techniques. Results— Twelve patients (mean age 63.2±2.3 years) completed the protocol. There was no treatment order effect. Cerebral vasomotor reactivity was significantly greater after perindopril treatment (percent change from baseline +18.8±10.1% after perindopril, −4.6±4.1% after placebo; P =0.032). Dosing with perindopril did not affect resting cerebral blood flow velocity (percent change from baseline +3.1±9.5% after perindopril, −0.6±5.4% after placebo), nor was there a change in resting blood pressure (+1.8 mm Hg±3.1 after perindopril, +1.4 mm Hg±2.5 after placebo). Conclusions— This study provides evidence of a significant improvement in cerebral vasomotor reactivity induced by perindopril, beyond any effect on blood pressure. The results suggest a possible mechanism for the beneficial effect of ACE inhibition on stroke risk observed in recent clinical trials, and suggest a role for the renin-angiotensin axis in the pathophysiology of subcortical small vessel disease.Keywords
This publication has 15 references indexed in Scilit:
- Acetazolamide as a vasodilatory stimulus in cerebrovascular diseases and in conditions affecting the cerebral vasculatureEuropean Journal of Neurology, 2003
- Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololPublished by Elsevier ,2002
- Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attackThe Lancet, 2001
- Costs, quality of life and disease severity in multiple sclerosis: a cross‐sectional study in SwedenEuropean Journal of Neurology, 2001
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Cerebral hemodynamics in young hypertensive subjects and effects of atenolol treatmentPublished by Elsevier ,1998
- Impairment of Cerebrovascular Reactivity in Long-Term Type 1 DiabetesDiabetes, 1997
- Differential systemic and regional hemodynamic profiles of four angiotensin-I converting-enzyme inhibitors in the ratCardiovascular Drugs and Therapy, 1989
- Effect of captopril (a converting enzyme inhibitor) on blood-brain barrier permeability and cerebral blood flow in normotensive ratsNeuropharmacology, 1987
- Effect of Contrast Material, Hypercapnia, Hyperventilation, Hypertonic Glucose and Papaverine on the Diameter of the Cerebral ArteriesInvestigative Radiology, 1967